STOCK TITAN

December 2022 Stock Losers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of December 2022 Every stock ranked by its December 2022 gain, with or without news

100

Ranked drops

-78.28%

Largest, THRD

95.9%

Below baseline, day +5

10.2%

Median deeper below baseline, day +5

Filter and sort
Rows

100 ranked drops in December 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 THRD -78.28% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results (terminated) Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

07:00 ET premarket

2 CORZ Also on the opposite board this month on both boards -75.53% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Core Scientific Announces Comprehensive Restructuring Transaction

04:50 ET premarket

3 GOSS -74.60% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH

07:15 ET premarket

4 AGFY -69.87% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Agrify Announces Launch of Public Offering

16:05 ET after hours

5 EIGR -69.53% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Eiger Announces Both Lonafarnib-based Treatments in Pivotal Phase 3 D-LIVR Trial in Hepatitis Delta Virus (HDV) Achieved Statistical Significance Against Placebo in Composite Primary Endpoint

08:00 ET premarket

6 COSM Also on the opposite board this month on both boards -67.01% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market

09:12 ET premarket

7 BVXV -58.62% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution BiondVax Announces Pricing of $8 Million Underwritten Public Offering

08:48 ET premarket

8 IBIO -57.88% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution iBio Announces Proposed Underwritten Public Offering

16:01 ET after hours

9 AMTI release reads positive -57.77% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 57.77% Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis

17:30 ET after hours

10 CTIB -54.20% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Yunhong CTI Ltd. Provides Update on Yunhong Biotechnology, Inc.

10:00 ET intraday

11 MGTA -52.71% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial

09:00 ET premarket

12 IRON -50.89% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Disc Medicine Announces Completion of Merger with Gemini Therapeutics

17:15 ET after hours

13 AXLA release reads positive -50.78% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 50.78% Axcella Announces Program Reprioritization and Corporate Restructuring

20:01 ET after hours

14 QTNT -50.01% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market

16:05 ET after hours

15 DS -49.52% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Drive Shack Inc. Announces Intention to Voluntarily Delist and Deregister its Securities

16:43 ET after hours

16 RLMD release reads positive -47.84% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 47.84% Relmada Therapeutics Announces Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder

16:05 ET after hours

17 GIII release reads positive -44.66% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session Release reads positive, stock fell 44.66% PVH Corp. Extends Licenses With G-III Apparel Group, Ltd. as Part of a Multi-Year Transition to Bring Core Product Categories In-House

16:16 ET after hours

18 AZYO -40.58% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock

16:08 ET after hours

19 AVYA release reads positive -40.47% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 40.47% Avaya Discloses Certain Information Related to Ongoing Constructive Discussions with Financial Stakeholders

09:15 ET premarket

20 ACET -39.64% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

10:00 ET intraday

21 MRDB -39.64% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition MariaDB Completes Merger and Lands on NYSE as “MRDB”

06:08 ET premarket

22 DAKT Also on the opposite board this month on both boards -39.16% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Daktronics, Inc. Announces Date Change for Second Quarter Fiscal 2023 Financial Results

18:20 ET after hours

23 NERV -39.15% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

08:00 ET premarket

24 AUTL -38.13% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis

16:01 ET after hours

25 THTX -36.02% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Theratechnologies Announces Update from Ongoing TH1902 Study

18:30 ET after hours

26 NVAX -34.30% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Novavax Announces Proposed $125 Million Public Offering of Common Stock

16:15 ET after hours

27 MEIP -33.52% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MEI Pharma Initiates Strategic Realignment

17:01 ET after hours

28 WULF -33.48% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury TeraWulf Significantly Increases Expected Q1 2023 Self-Mining Hash Rate at No Additional Cost and Announces Repayment of Certain Debt

08:30 ET premarket

29 DSGN -33.33% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress

16:01 ET after hours

30 ACER release reads positive -33.33% against the close of 12/23/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Release reads positive, stock fell 33.33% Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders

08:30 ET premarket

31 RCUS -32.51% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study

17:00 ET after hours

32 VNDA -31.14% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation

15:15 ET intraday

33 CSBR -31.04% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

16:00 ET after hours

34 FUTU -31.00% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Futu Provides Regulatory Update in China

07:59 ET premarket

35 SATL release reads positive -30.59% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 30.59% Satellogic Provides Business Update

16:01 ET after hours

36 LE -30.36% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lands’ End Announces Third Quarter Fiscal 2022 Results

06:45 ET premarket

37 TMPO -30.26% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Tempo Provides Third Quarter 2022 Financial and Operational Results Commentary and 2022 and 2023 Guidance

02:36 ET premarket

38 MIRO -30.24% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP

17:30 ET after hours

39 NEPT -30.00% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Neptune Reports Fiscal Second Quarter 2023 Financial Results

16:01 ET after hours

40 SQZ release reads positive -29.08% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 29.08% SQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive Officer

16:30 ET after hours

41 LVTX -28.96% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results LAVA Therapeutics Announces Updated Data from the Phase 1/2a Clinical Trial of LAVA-051 at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

10:00 ET intraday

42 UPH release reads positive -28.84% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads positive, stock fell 28.84% UpHealth Announces Results of First Annual Stockholder Meeting

16:11 ET after hours

43 CNTX release reads positive -28.42% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 28.42% Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer

07:30 ET premarket

44 BNED -27.45% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Barnes & Noble Education Reports Second Quarter Fiscal Year 2023 Financial Results

07:00 ET premarket

45 HOTH Also on the opposite board this month on both boards -27.24% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Hoth Therapeutics Announces $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

20:00 ET after hours

46 KSPN -27.24% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Kaspien Holdings Inc. Reports Fiscal Third Quarter 2022 Results

16:30 ET after hours

47 GH release reads positive -27.14% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 27.14% Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer

16:16 ET after hours

48 SLNH Also on the opposite board this month on both boards -27.02% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Soluna Holdings, Inc Announces Registered Direct Offering

09:00 ET premarket

49 FFIE Also on the opposite board this month release reads positive on both boards -26.38% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 26.38% Faraday Future Announces Plans to Start Production of FF 91 Futurist in March 2023, Outlines Financing Progress and Completion of Product Upgrades

19:00 ET after hours

50 MHUA -26.20% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors

08:30 ET premarket

51 CGTX -25.93% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cognition Therapeutics Presents Scientific Rationale, Clinical Biomarker and Preclinical Data supporting a Phase 2 Clinical Trial with CT1812 in Geographic Atrophy Secondary to Dry AMD

07:30 ET premarket

52 HLF -25.41% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Herbalife Nutrition Announces Proposed Offering of $250 Million Aggregate Principal Amount of Convertible Senior Notes

16:05 ET after hours

53 UNCY release reads positive -25.37% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 25.37% Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of Renazorb

08:30 ET premarket

54 DBI -25.23% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Designer Brands Inc. Reports Third Quarter 2022 Financial Results

06:45 ET premarket

55 BAM -24.91% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Brookfield Corporation Successfully Completes Distribution of 25% Interest in its Asset Management Business

18:00 ET after hours

56 ENZ -24.32% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

17:29 ET after hours

57 ASTI -23.55% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ascent Solar Technologies Secures $50 Million Equity-Based Financing

08:30 ET premarket

58 MRTX -22.89% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

18:05 ET after hours

59 ERAS -22.30% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution catalyst from a later release the same session Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib

07:34 ET premarket

60 ENOB -22.26% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

17:20 ET after hours

61 BAMR -22.09% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Brookfield Reinsurance successfully completes Special Distribution

18:09 ET after hours

62 APRN -22.05% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Blue Apron Launches a Fireside Feast Box as Its Next Limited-Time, Seasonal Meal Kit

08:30 ET premarket

63 OCX -21.95% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Oncocyte Announces Initiatives to Focus Corporate Strategy

08:00 ET premarket

64 CURV -21.55% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Torrid Reports Third Quarter Fiscal 2022 Results and Updates Fiscal 2022 Outlook

16:05 ET after hours

65 ATNF -21.52% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution 180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

08:00 ET premarket

66 LOVE -21.25% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings The Lovesac Company Reports Third Quarter Fiscal 2023 Financial Results

07:00 ET premarket

67 ARBK Also on the opposite board this month on both boards -21.03% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Argo Blockchain PLC Announces Nasdaq Notification - Minimum Bid Price Deficiency

02:00 ET premarket

68 RPID -20.98% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Rapid Micro Biosystems Concludes Review of Strategic Alternatives

08:00 ET premarket

69 AVXL Also on the opposite board this month on both boards -20.50% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022

16:30 ET after hours

70 CFRX -20.31% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement

08:01 ET premarket

71 ZUO -20.11% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Zuora Reports Third Quarter Fiscal 2023 Results

16:15 ET after hours

72 TRDA -19.76% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Entrada Therapeutics Announces Clinical Hold on IND Application for ENTR-601-44 in Duchenne Muscular Dystrophy

16:30 ET after hours

73 PERF -19.73% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Perfect Corp. Introduces Unique High-Precision Real-Time Live AR & AI-Powered Virtual Try-On Technology for 3D Necklaces, Elevating Jewelry Shopping Experiences

06:45 ET premarket

74 TIL -19.67% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Instil Bio Announces Prioritization of Genetically Engineered CoStAR-TIL Program with ITIL-306 in Advanced Solid Tumors and Reduction in Workforce

07:00 ET premarket

75 SKYX -19.60% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement SKYX to Initiate Pre-Sales Campaign for its Award Winning Smart SkyPlug Product on Monday, December 19, 2022

09:00 ET premarket

76 SWBI -19.58% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Smith & Wesson Brands, Inc. Reports Second Quarter Fiscal 2023 Financial Results

16:05 ET after hours

77 SHLS -19.57% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution catalyst from a later release the same session Shoals Technologies Group, Inc. Announces CEO Succession Plan

16:05 ET after hours

78 DUOT -19.41% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Duos Technologies Appoints Thomas Hughes as Vice President of Sales

08:00 ET premarket

79 VEON -19.04% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Turkcell and VEON’s Jazz Announce Strategic Partnership for BiP

04:59 ET premarket

80 TSP -19.03% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement TuSimple and Navistar Provide Update on Joint Development Agreement

18:30 ET after hours

81 MNPR -18.97% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration

07:00 ET premarket

82 FCEL -18.71% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings FuelCell Energy Reports Fourth Quarter of Fiscal 2022 Results

07:30 ET premarket

83 JOB -18.61% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GEE Group Announces Results for the Fiscal 2022 Full Year and Fourth Quarter

16:15 ET after hours

84 ECOR -18.55% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement electroCore Announces Issuance of Two New U.S. Patents

08:00 ET premarket

85 OTIC -18.48% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Otonomy Provides Corporate Update

16:53 ET after hours

86 HEXO -18.37% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session HEXO Corp Announces Share Consolidation

17:00 ET after hours

87 EZPW -18.18% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution EZCORP Announces Private Offering of $175,000,000 of Convertible Senior Notes Due 2029

08:09 ET premarket

88 EVK -18.08% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Ever-Glory Announces Voluntary Delisting from the Nasdaq Global Market

02:00 ET premarket

89 LEV -17.98% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Lion Electric Announces Launch of Overnight Marketed Public Offering of Units

16:21 ET after hours

90 GREE -17.97% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Greenidge Generation Executes Term Sheet with Secured Lender NYDIG Regarding Debt Renegotiations; Provides Liquidity Update

07:00 ET premarket

91 KPTI -17.87% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients with Treatment-Naïve Myelofibrosis at ASH 2022

07:00 ET premarket

92 OGS -17.64% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ONE Gas Issues 2023 Financial Guidance

16:15 ET after hours

93 ARQQ -17.60% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Arqit Joins Fortinet Fabric-Ready Partner Program, Completes Integration to Enable Quantum-Safe Encryption

08:00 ET premarket

94 UTI -17.48% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Universal Technical Institute Reports Fiscal Year 2022 Fourth Quarter and Year-End Results

08:00 ET premarket

95 OLLI -17.47% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Ollie’s Bargain Outlet Holdings, Inc. Reports Third Quarter Fiscal 2022 Financial Results

07:30 ET premarket

96 RAD -17.23% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rite Aid Corporation Reports Fiscal 2023 Third Quarter Results

07:00 ET premarket

97 ZEV -17.12% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Lightning eMotors Receives Continued Listing Standards Notice from the NYSE

16:05 ET after hours

98 CKPT -17.01% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

08:00 ET premarket

99 DLTH -16.84% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Duluth Holdings Inc. Announces Third Quarter 2022 Financial Results

06:45 ET premarket

100 FG -16.79% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Fidelity National Financial Completes Planned Transaction to Distribute Approximately 15% Ownership of F&G to FNF Shareholders

07:30 ET premarket

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 449 smaller events this month are held out of this month's eligible pool; switch to include them. 226 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2022, the median decliner was 10.2% deeper below its pre-news close five sessions later; the largest catalyst group was Other Announcement, 28 of the 100 events, at a median of -22.9%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Other Announcement 28 28.0% -22.9% -28.2% of 27 96.3% of 27
Earnings 21 21.0% -21.5% -27.0% 95.2% of 21
Clinical Trial Results 17 17.0% -32.5% -43.0% 100.0% of 17
Offering / Dilution 16 16.0% -26.2% -38.6% 93.8% of 16
FDA & Regulatory 5 5.0% Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 13 events: M&A / Acquisition, Contract / Partnership, Crypto & Treasury, Uplisting / Compliance, Leadership Change.

How much of the drop held

Horizon Still below the pre-news close close to close Median change since the measured close as a share of the drop
Day +1 99.0% of 100 6.7% deeper below baseline, of 100
Day +5 95.9% of 98 10.2% deeper below baseline, of 98
Month end 94.7% of 95 13.1% deeper below baseline, of 95
Month end falls before day +5 for 5 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2022

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
No company moved twice or more this month.

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
CVNA 2022-11, 2022-10, 2022-09 -38.95%
AGFYthis month too 2022-11, 2022-10 -37.82%
PNT 2022-11, 2022-09 -37.42%
VLTA 2022-11, 2022-09 -25.69%
SLNHthis month too 2022-10, 2022-09 -33.33%
LITM 2022-10, 2022-09 -40.88%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market50.0%
  • Intraday4.0%
  • After hours46.0%

Volume against normal

  • Under 5x30 events, 30.3%
  • 5x to 20x44 events, 44.4%
  • Over 20x25 events, 25.3%

1 event has too little trading history for a relative volume, and is not in the tiers above.

Industry

  • Pharmaceutical Preparations21 events, 21.0%
  • Biological Products, (no Diagnostic Substances)6 events, 6.0%
  • Finance Services4 events, 4.0%
  • Services-prepackaged Software3 events, 3.0%
  • Retail-apparel & Accessory Stores2 events, 2.0%
  • Semiconductors & Related Devices2 events, 2.0%

23 other industries, 25 events

Industry not known: 37.0%

When the release and the price disagreed

13 events on this board carry the flag.

Flagged events sat 3.8 percentage points below the rest of the board five sessions later.

Median at day +5, flagged
-34.3%
Median at day +5, not flagged
-30.5%

Against November 2022

100 events in the comparable window.

November 2022 median -33.0%, selected from the 10,094 events in that month's eligible pool

December 2022 median -26.1%, 6.9 points shallower than November 2022. December 2022's median is taken over the 100 ranked rows, selected from the 5,912 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.